Duwe SC - Search Results

1

Prophylaxis and treatment of influenza: options, antiviral susceptibility, and existing recommendations.

Duwe SC, Schmidt B, Gärtner BC, Timm J, Adams O, Fickenscher H, Schmidtke M. Duwe SC, et al. GMS Infect Dis. 2021 Apr 30;9:Doc02. doi: 10.3205/id000071. eCollection 2021. GMS Infect Dis. 2021. PMID: 34113534 Free PMC article. Review.

2

Frequency of genotypic and phenotypic drug-resistant HIV-1 among therapy-naive patients of the German Seroconverter Study.

Duwe S, Brunn M, Altmann D, Hamouda O, Schmidt B, Walter H, Pauli G, Kücherer C. Duwe S, et al. J Acquir Immune Defic Syndr. 2001 Mar 1;26(3):266-73. doi: 10.1097/00042560-200103010-00010. J Acquir Immune Defic Syndr. 2001. PMID: 11242200

3

Influenza viruses - antiviral therapy and resistance.

Duwe S. Duwe S. GMS Infect Dis. 2017 Apr 25;5:Doc04. doi: 10.3205/id000030. eCollection 2017. GMS Infect Dis. 2017. PMID: 30671326 Free PMC article. Review.

4

Insights into the direct anti-influenza virus mode of action of Rhodiola rosea.

Döring K, Langeder J, Duwe S, Tahir A, Grienke U, Rollinger JM, Schmidtke M. Döring K, et al. Phytomedicine. 2022 Feb;96:153895. doi: 10.1016/j.phymed.2021.153895. Epub 2021 Dec 14. Phytomedicine. 2022. PMID: 35026524 Free article.

5

Preparing for the Next Influenza Season: Monitoring the Emergence and Spread of Antiviral Resistance.

Oh DY, Milde J, Ham Y, Ramos Calderón JP, Wedde M, Dürrwald R, Duwe SC. Oh DY, et al. Among authors: duwe sc. Infect Drug Resist. 2023 Feb 15;16:949-959. doi: 10.2147/IDR.S389263. eCollection 2023. Infect Drug Resist. 2023. PMID: 36814825 Free PMC article.

6

Prospective surveillance of antiviral resistance in hospitalized infants less than 12 months of age with A(H3N2) influenza infection and treated with oseltamivir.

Rath B, Chen X, Spies V, Muehlhans S, Obermeier P, Tief F, Seeber L, Karsch K, Milde J, Skopnik H, Schweiger B, Duwe SC. Rath B, et al. Among authors: duwe sc. Antivir Ther. 2017;22(6):515-522. doi: 10.3851/IMP3141. Epub 2017 Feb 16. Antivir Ther. 2017. PMID: 28205506

7

A new and rapid genotypic assay for the detection of neuraminidase inhibitor resistant influenza A viruses of subtype H1N1, H3N2, and H5N1.

Duwe S, Schweiger B. Duwe S, et al. J Virol Methods. 2008 Nov;153(2):134-41. doi: 10.1016/j.jviromet.2008.07.017. Epub 2008 Sep 19. J Virol Methods. 2008. PMID: 18725246

8

Trends in respiratory virus circulation following COVID-19-targeted nonpharmaceutical interventions in Germany, January - September 2020: Analysis of national surveillance data.

Oh DY, Buda S, Biere B, Reiche J, Schlosser F, Duwe S, Wedde M, von Kleist M, Mielke M, Wolff T, Dürrwald R. Oh DY, et al. Lancet Reg Health Eur. 2021 Jul;6:100112. doi: 10.1016/j.lanepe.2021.100112. Epub 2021 Jun 7. Lancet Reg Health Eur. 2021. PMID: 34124707 Free PMC article.

9

Different populations of A(H1N1)pdm09 viruses in a patient with hemolytic-uremic syndrome.

Fu Y, Wedde M, Smola S, Oh DY, Pfuhl T, Rissland J, Zemlin M, Flockerzi FA, Bohle RM, Thürmer A, Duwe S, Biere B, Reiche J, Schweiger B, Mache C, Wolff T, Herrler G, Dürrwald R. Fu Y, et al. Int J Med Microbiol. 2024 Mar;314:151598. doi: 10.1016/j.ijmm.2024.151598. Epub 2024 Jan 11. Int J Med Microbiol. 2024. PMID: 38237287 Free article.

10

Genotypic and phenotypic resistance of pandemic A/H1N1 influenza viruses circulating in Germany.

Duwe SC, Wedde M, Birkner P, Schweiger B. Duwe SC, et al. Antiviral Res. 2011 Jan;89(1):115-8. doi: 10.1016/j.antiviral.2010.11.001. Epub 2010 Nov 9. Antiviral Res. 2011. PMID: 21070812

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

25 results

Search Page